DNLI - Denali Therapeutics down 3% premarket on pricing equity offering January, 29 2020 05:07 AM Denali Therapeutics Inc. Denali Therapeutics (NASDAQ:DNLI) has priced its public offering of 7,826,087 common shares at $23/share, for expected gross proceeds of $180M.More news on: Denali Therapeutics Inc., Healthcare stocks news, Read more ...